Defiance Quantum ETF에 대한 매도 수량은 투자자에게 Defiance Quantum ETF의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Defiance Quantum ETF (NASDAQ:QTUM), 공매도 수량 보고

Technology

Industrials

Communication Services

Other

Basic Materials

Consumer Cyclical

 The Fund uses a passive management (or indexing) approach to track the total return performance, before fees and expenses, of the Index, The Fund will generally use a replication strategy to achieve its investment objective, meaning the Fund will generally invest in all of the component securities of the Index in the same approximate proportions as in the Index. However, the Fund may use a representative sampling strategy, meaning it may invest in a sample of the securities in the Index whose risk, return, and other characteristics closely resemble the risk, return, and other characteristics of the Index as a whole, when the Funds sub-adviser believes it is in the best interests of the Fund (e.g., when replicating the Index involves practical difficulties or substantial costs, an Index constituent becomes temporarily illiquid, unavailable, or less liquid, or as a result of legal restrictions or limitations that apply to the Fund but not to the Index)., The Fund generally may invest in securities or other investments not included in the Index, but which the Funds sub-adviser believes will help the Fund track the Index. For example, the Fund may invest in securities that are not components of the Index to reflect various corporate actions and other changes to the Index (such as reconstitutions, additions, and deletions).

Lockheed Martin Corp

Northrop Grumman Corp.

Accenture Plc

International Business Machines Corp.

Orange Sa Adr

Raytheon Co.

Nippon Telegraph & Telephone Corp

Juniper Networks Inc.

Koninklijke Kpn Nv

Wipro Ltd. Adr

Defiance Quantum ETF

Equities

Markets

Movers

General

IONQ

NVDA

QBTS

QTUM

QUBT

RGTI

TMAT

양자 컴퓨팅 관련 주식들이 산업 발전, 주요 파트너십 그리고 투자자들의 높은 열기에 힘입어 큰 폭으로 상승하고 있다. 약물 발견, 암호화 및 인공지능(AI) 등 다양한 분야에서의 잠재력으로 인해 이 신흥 기술 분야가 주목받고 있으며, 양자 컴퓨팅은 투자자들에게 주요 관심사로 자리잡고 있다.

양자 컴퓨팅 주식 개요: D-웨이브, 리제티, 아이온큐가 폭발적인 성장으로 선두

Quantum - United States dollar

News

Management

ENVX

Enovix Corporation Announced Its CFO Farhan Ahmad Has Left The Company And That It Is Searching For A New CFO

Loop Capital analyst Rob Sanderson maintains AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) with a Buy and raises the price target from $385 to $450.

Price Target

Analyst Ratings

Loop Capital Maintains Buy on AppLovin, Raises Price Target to $450

As Part of a Procedural Measure due to a Timing Requirement from Nasdaq, Trading is Expected to Temporarily Transition to OTC Markets and, Upon Consummation of the Business Combination, will Relist on Nasdaq
FTAC Emerald Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLD#NASDAQ">FLD</a>) ("FTAC Emerald"), a publicly-traded special purpose acquisition company, today announced that it will change its ticker symbol for its Common Stock. Beginning on December 18, 2024, FTAC Emerald's Common Stock will begin trading under the new ticker symbol FLDD. FTAC Emerald's Units and Warrants will continue to trade under the symbols FLDDU, and FLDDW, respectively.
As anticipated as a procedural measure due to a timing requirement by Nasdaq, FTAC Emerald's common stock, units, and warrants are expected to transition from Nasdaq to OTC Markets. The new ticker symbol will ensure uninterrupted market activity for shareholders. FTAC Emerald's ongoing business combination agreement with Fold, a pioneering bitcoin financial services company, will be unaffected by the transition of trading venue.

FTAC Emerald Acquisition Corp. Announces Change Of Ticker Symbol Of Its Common Stock To "FLDD" Commencing December 18, 2024

Contracts

SAIC

Science Applications Internationnal Wins Prime Position On $1.B Personal And Readiness Infrastructure Support Management Award Task Order Contract

On Monday, Danish pharmaceutical firm Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) announced plans to invest approximately $1.20 billion (8.5 billion Danish kroner) to establish a new production facility in Odense, Denmark.
The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site. The new site will <a target="_blank" href="https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=915079" rel="noreferrer noopener">feature</a> a finished production facility and warehouse of over 40,000 m2.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42489755/novo-nordisks-ozempic-potentially-linked-to-rare-vision-loss-risk-but-study-concludes-absolute-increase-in-risk-minimal" rel="noreferrer noopener">Novo Nordisk's Ozempic Potentially Linked To Rare Vision Loss Risk, But Absolute Risk Is Low: Study</a>
Designed to be modular and flexible, it will accommodate multiple product types within rare diseases, such as hemophilia. Construction work has commenced and is scheduled to be completed in 2027.
The investment is expected to create 400 permanent jobs upon completion of the facilities. Up to 1,000 external employees will be working on-site during the construction process.
On Friday, Novo Holdings announced it had <a target="_blank" href="https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=915078" rel="noreferrer noopener">fulfilled</a> all regulatory requirements to finalize its acquisition of Catalent Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTLT#NYSE">CTLT</a>).
The closure comes amid a coalition of unions, consumer groups, and public interest organizations voicing strong opposition to&nbsp;Novo Holdings'&nbsp;proposed&nbsp;$16.5 billion <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41409503/after-us-senator-unions-urge-federal-trade-commission-to-block-novos-16-5b-acquisition-of-catalen" rel="noreferrer noopener">acquisition&nbsp;of&nbsp;Catalent</a>.
Last week, the European Commission <a target="_blank" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=915074" rel="noreferrer noopener">approved</a> Novo Holdings' acquisition of Catalent and Novo Nordisk's subsequent acquisition of three manufacturing sites from Novo Holdings.
The deal for the three sites is expected to close in the coming days. Once completed, the acquisition will affect Novo Nordisk's financial outlook, including:
2024 Impact: A slight negative effect on operating profit growth and a reduction in free cash flow by $11.7 billion, the acquisition's cost. The ongoing 20 billion Danish krone share buyback program remains unaffected.
2025 Impact: Operating profit growth is projected to face a moderate negative impact, with interest payments from debt financing affecting net financial items. Novo Nordisk does not plan to launch a share buyback program in 2025.
Price Action: At last check on Monday, NVO stock was up 0.93% at $107.94 during the premarket session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42490115/despite-higher-valuations-some-life-sciences-tools-stocks-create-good-opportunities-analyst" target="_blank" rel="noreferrer noopener">Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst</a></li>
</ul>
Photo via Shutterstock

Biotech

Large Cap

Health Care

CTLT

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

Stonepeak To Acquire Forgital Group From Carlyle; Terms Not Disclosed

In the current session, the stock is trading at $143.15, after a 0.37% spike. Over the past month, Abercrombie &amp; Fitch Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) stock increased by 0.03%, and in the past year, by 56.79%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1734355832_0.png" alt="Past Year Chart" />

<h3>Comparing Abercrombie &amp; Fitch P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 30.41 in the Specialty Retail industry, Abercrombie &amp; Fitch Inc. has a lower P/E ratio of 14.12. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734355832_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Abercrombie & Fitch Inc's Price Over Earnings

JP Morgan analyst Matthew Boss maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Overweight and raises the price target from $66 to $75.

JP Morgan Maintains Overweight on Tapestry, Raises Price Target to $75

Evercore ISI Group analyst Liisa Bayko maintains Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) with a Outperform and lowers the price target from $7 to $5.

EDIT

Evercore ISI Group Maintains Outperform on Editas Medicine, Lowers Price Target to $5

Wedbush analyst Daniel Ives maintains SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) with a Outperform and raises the price target from $10 to $22.

SOUN

Wedbush Maintains Outperform on SoundHound AI, Raises Price Target to $22

BMO Capital analyst Michael Zaremski maintains Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) with a Outperform and lowers the price target from $273 to $267.

BMO Capital Maintains Outperform on Progressive, Lowers Price Target to $267

Crypto
<ul>
<li><a href="https://www.benzinga.com/24/12/42503379/balaji-srinivasan-contrasts-ais-reputation-as-making-it-easy-to-fake-things-with-cryptos-tamper-proof-technology">Former Coinbase Tech Chief Contrasts AI&#8217;s Reputation As Making It Easy To Fake Things With Crypto&#8217;s Tamper-Proof Technology</a></li>
<li><a href="https://www.benzinga.com/24/12/42502213/new-crypto-accounting-standards-from-todaywill-it-boost-bitcoins-corporate-adoption">New Crypto Accounting Standards Go Into Effect Today: Will They Boost Bitcoin&#8217;s Corporate Adoption?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42501517/whale-accumulation-powers-bitcoins-bull-run-but-retail-still-the-king-in-ownership">Bitcoin&#8217;s Bull Run Gets A Boost From Whale Accumulators, But Retail Still The King In Ownership</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/12/42500884/trump-backed-world-liberty-financials-purchases-trigger-strong-rally-in-these-defi-tokens">Trump-Backed World Liberty Financial&#8217;s Purchases Trigger Strong Rally In These DeFi Tokens</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/12/42500721/bitcoin-breaks-106k-ethereum-dogecoin-rally-ahead-of-key-fed-meet-but-top-analyst-triggers-anxiety-with-this-observation">Bitcoin Breaks $106K, Ethereum, Dogecoin Rally Ahead Of Key Fed Meet But Top Analyst Triggers Anxiety With This Observation</a></li>
</ul>
US Markets­­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/24/12/42504194/us-stocks-to-open-higher-ahead-of-feds-decision-this-week-analyst-says-santa-comes-later-in-december">US Stocks To Open Higher Ahead Of Fed&#8217;s Decision This Week: Analyst Says &#8216;Santa Comes Later In December&#8217;</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42505162/trump-reportedly-considering-executive-order-to-establish-strategic-bitcoin-reserve">Trump Reportedly Considering Executive Order To Establish Strategic Bitcoin Reserve</a></li>
<li><a href="https://www.benzinga.com/news/24/12/42505666/softbanks-masayoshi-son-to-reportedly-announce-100b-us-investment-during-meeting-with-trump">Softbank&#8217;s Masayoshi Son To Reportedly Announce $100B US Investment During Meeting With Trump</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42502979/chamath-palihapitiya-says-trumps-proposed-tariffs-would-act-as-reverse-subsidy-for-american-companies-to-compete-with-chinese-counterparts">Chamath Palihapitiya Says Trump&#8217;s Proposed Tariffs Would Act As &#8216;Reverse Subsidy For American Companies&#8217; To Compete With Chinese Counterparts</a></li>
<li><a href="https://www.benzinga.com/news/24/12/42500701/trumps-security-adviser-pick-warns-of-gaps-in-our-agencies-amid-growing-drone-sightings-across-us-calls-for-expanding-israels-iron-dome-for-defense">Trumps&#8217; Security Adviser Pick Warns Of &#8216;Gaps In Our Agencies&#8217; Amid Growing Drone Sightings Across US, Calls For Expanding Israel&#8217;s Iron Dome For Defense</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/12/42502069/gold-poised-for-its-best-year-in-a-decade-while-bitcoin-surges-analysts-eye-2025-as-a-golden-era-for-precious-metal-amid-michael-saylors-push-for-btc-as-a-reserve-asset">Gold Poised For Its Best Year In A Decade While Bitcoin Surges: Analysts Eye 2025 As A Golden Era For Precious Metal Amid Michael Saylor&#8217;s Push For BTC As A Reserve Asset</a></li>
</ul>
World Economy
<ul>
<li><a href="https://www.benzinga.com/markets/forex/24/12/42504634/asia-and-europe-markets-decline-dollar-hovers-3-week-high-global-markets-today-while-us-slept">Asia And Europe Markets Decline, Dollar Hovers 3-Week High &#8211; Global Markets Today While US Slept</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42503221/microstrategy-shares-surge-nearly-7-amid-nasdaq-100-inclusion-and-bitcoins-new-record-high">MicroStrategy Shares Surge Nearly 7% Amid Nasdaq 100 Inclusion And Bitcoin&#8217;s New Record High</a></li>
<li><a href="https://www.benzinga.com/24/12/42502992/sonys-astro-bot-takes-the-game-of-the-year-crown-but-the-playstation-5-platformer-has-divided-the-internet-overnight">Sony&#8217;s Astro Bot Takes &#8216;Game Of The Year&#8217; Crown, But The PlayStation 5 Platformer Divides The Internet</a></li>
<li><a href="https://www.benzinga.com/media/24/12/42501665/apples-2025-airtag-to-feature-iphone-15s-ultrawide-band-chip-for-smarter-longer-range-tracking-report">Apple&#8217;s 2025 AirTag To Feature iPhone 15&#8217;s Ultrawide-Band Chip For Smarter, Longer-Range Tracking: Report</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42501530/ex-google-ceo-eric-schmidt-sees-ai-drones-as-the-future-of-warfare-but-stresses-need-for-meaningful-human-control">Ex-Google CEO Eric Schmidt Sees AI Drones As The Future Of Warfare But Stresses Need For &#8216;Meaningful Human Control&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/global/24/12/42501141/amazon-faces-strike-threat-over-labor-disputes-as-teamsters-push-for-fair-contract-ahead-of-crucial-holiday-season">Amazon Teamsters Threaten Strike Ahead Of Crucial Holiday Season: &#8216;We Are Going To Hold This Company Accountable&#8217;</a></li>
<li><a href="https://www.benzinga.com/media/24/12/42500942/apple-eyes-2026-to-launch-foldable-iphones-and-ultralight-devices-as-it-looks-to-revitalize-sales-momentum-report">Apple Eyes 2026 To Launch Foldable iPhones And Ultralight Devices As It Looks To Revitalize Sales Momentum: Report</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42500167/could-apple-set-revolutionize-tablet-market-with-18-8-inch-foldable-ipad">Could Apple Set Revolutionize Tablet Market With 18.8-Inch Foldable iPad?</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42505310/tesla-prepares-for-holiday-rush-tapping-into-global-supercharger-demand-to-drive-revenue-growth">Tesla Prepares For Holiday Rush, Tapping Into Global Supercharger Demand To Drive Revenue Growth</a></li>
<li><a href="https://www.benzinga.com/24/12/42503675/alphabet-ceo-sundar-pichai-names-tesla-as-main-competitior-to-its-waymo-robotaxi-unit">Sundar Pichai Names Tesla As Top Competitor To Alphabet&#8217;s Waymo In Autonomous Driving Race</a></li>
<li><a href="https://www.benzinga.com/24/12/42502841/wedbush-analyst-raises-teslas-price-target-to-515">Tech Bull Raises Tesla Price Target To $515, Predicts $1 Trillion AI Opportunity Under Trump White House: &#8216;Total Game Changer&#8217;</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42502306/tesla-says-cybertruck-drivers-can-now-get-max-charging-rate-of-up-to-325-kw-on-select-v4-supercharger-posts">Tesla Says Cybertruck Drivers Can Now Get Max Charging Rate Of Up To 325 kW On Select V4 Supercharger Posts</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42501918/teslas-texas-lithium-plant-begins-operations-amid-market-oversupply">Tesla&#8217;s Texas Lithium Plant Begins Operations Amid Market Oversupply</a></li>
<li><a href="https://www.benzinga.com/24/12/42501487/cybertruck-production-rate-was-reduced-even-before-decembers-production-pause-says-tesla-researcher">Tesla&#8217;s Cybertruck Production Rate Was Reduced Even Before December&#8217;s Pause, Says Researcher</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42500865/ark-invests-cathie-wood-predicts-rapid-robotaxi-market-shift-as-waymo-gains-on-lyft-in-san-francisco">Ark Invest&#8217;s Cathie Wood Predicts Rapid Robotaxi Market Shift As Waymo Gains On Lyft In San Francisco</a></li>
</ul>
Communication
<ul>
<li><a href="https://www.benzinga.com/24/12/42501178/meta-warns-ai-generated-content-can-be-a-threat-as-instagram-boss-suggests-always-considering-who-it-is-that-is-speaking">Instagram Head Wants X&#8217;s Community Notes-Like Feature To Offer Context On What People Are Saying, Warns Against Generative AI Blurring Lines Between Reality And Fiction</a></li>
<li><a href="https://www.benzinga.com/startups/24/12/42500207/cnn-and-msnbc-ratings-plunge-by-half-reaching-30-year-lows-and-billionaires-are-paying-attention">CNN And MSNBC Ratings Plunge By Half, Reaching 30-Year Lows – And Billionaires Are Paying Attention</a></li>
</ul>
Industrial
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/24/12/42505835/honeywell-advances-strategic-review-explores-aerospace-business-separation">Honeywell Advances Strategic Review, Explores Aerospace Business Separation</a></li>
<li><a href="https://www.benzinga.com/markets/24/12/42503776/weapon-maker-axon-shares-rise-in-monday-pre-market-whats-going-on">Weapon-Maker Axon Shares Rise In Monday Pre-Market: What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/24/12/42503260/general-mills-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-2">General Mills Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
<li><a href="https://www.benzinga.com/news/global/24/12/42502247/trumps-ex-secretary-of-state-mike-pompeo-backs-nippon-steels-149b-acquisition-of-us-steel-citing-national-security-concerns">Trump&#8217;s Ex-Secretary Of State Mike Pompeo Backs Nippon Steel&#8217;s $14.9B Acquisition Of US Steel Citing National Security Concerns</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42500980/palantir-surges-over-3-in-overnight-trading-after-army-navy-game-spotlight-elon-musk-and-trumps-presence-and-nasdaq-100-inclusion">Palantir Surges Over 3% In Overnight Trading After Army-Navy Game Spotlight, Elon Musk And Trump&#8217;s Presence, And Nasdaq 100 Inclusion</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/24/12/42504517/why-edgewise-therapeutics-shares-are-trading-higher-by-over-26-here-are-20-stocks-moving-premarket">Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket</a></li>
</ul>
Financial
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/12/42502201/unitedhealthcare-ceos-murder-prompts-industry-scrutiny-expert-urges-addressing-3-key-issues">UnitedHealthcare CEO&#8217;s Tragic Death Sparks Urgent Debate Over US Insurance Industry Reform: Expert Says &#8216;Everything Is Buried Under Layers Of Everything Else</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/24/12/42501037/famed-investor-dennis-gartman-chooses-gold-over-bitcoin-i-prefer-centuries-bet-over-monthly-bet">Wall Street Veteran Dennis Gartman Chooses Gold Over Bitcoin Despite BTC&#8217;s Record-Breaking Bull Run: &#8216;I Prefer Centuries Bet Over Monthly Bet&#8217;</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42500224/elon-musks-mother-opens-up-about-his-friendship-with-barron-trump-bonded-over-out-of-this-world-exploration">Elon Musk&#8217;s Mother Opens Up About His Friendship With Barron Trump: &#8216;Bonded Over Out-Of-This-World Exploration&#8217;</a></li>
<li><a href="https://www.benzinga.com/startups/24/12/42500031/elon-musk-jokingly-refers-to-apple-as-the-tesla-graveyard-and-says-steve-jobs-was-kind-of-a-jerk-to-him-when-they-met-at-a-party">Elon Musk &#8216;Jokingly&#8217; Refers To Apple As The &#8216;Tesla Graveyard&#8217; And Says Steve Jobs Was &#8216;Kind Of A Jerk&#8217; To Him When They Met At A Party</a></li>
</ul>
Energy
<ul>
<li><a href="https://www.benzinga.com/24/12/42504655/shell-greenlights-bonga-north-deep-water-project-targeting-110000-bpd-output">Shell Greenlights Bonga North Deep-Water Project, Targeting 110,000 Bpd Output</a></li>
<li><a href="https://www.benzinga.com/government/regulations/24/12/42506074/mexico-and-el-salvador-ponder-different-mining-stances">Mexico And El Salvador Ponder Different Mining Stances</a></li>
</ul>
Photo via Shutterstock

$BTC

$ETH

TSLA

Trump Eyes Strategic Bitcoin Reserve; Amazon Teamsters Threaten Holiday Strike; Analyst Sparks Concern Amid Crypto Surge - Top Headlines Today While US Slept

Wedbush analyst Laura Chico reiterates Neurocrine Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) with a Outperform and maintains $148 price target.

Reiteration

NBIX

Wedbush Reiterates Outperform on Neurocrine Biosciences, Maintains $148 Price Target

Elon Musk is reportedly facing internal discussions about the risks of pursuing a higher security clearance for sensitive programs of SpaceX despite being the CEO. Concerns have been raised about potential government inquiries into Musk&#8217;s interactions with foreign nationals and past drug use.
What Happened: SpaceX&#8217;s legal team advised against Musk seeking a higher security clearance. The team feared that Musk might inadvertently reveal sensitive information during government questioning. This issue emerged as SpaceX&#8217;s involvement with national security agencies intensified. Although Musk holds a top-secret clearance, it does not grant access to certain classified programs, The Wall Street Journal <a href="https://www.wsj.com/tech/musk-spacex-security-clearance-secrets-b9774346">reported</a> on Monday.
According to the publication, Musk&#8217;s frequent communications with Russian President Vladimir Putin since late 2022 and his public drug use, including marijuana on a 2018 podcast, as factors in the extended review of his security clearance application. SpaceX&#8217;s legal team worried that pursuing a higher clearance could lead to Musk being denied or losing his existing clearance.
See Also:&nbsp;<a href="https://www.benzinga.com/24/12/42495770/trump-transition-team-advocates-for-abolishing-car-crash-reporting-rule-tesla-stands-to-gain?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Transition Team Advocates For Abolishing Car-Crash Reporting Rule, Tesla Stands To Gain: Report</a>
As President-elect Donald Trump announced Musk to lead the Department of Government Efficiency, there is potential for Musk to gain broader access to classified information. However, Trump has not yet publicly indicated whether he will grant such access. SpaceX is already preparing for the possibility by scouting secure facilities for Musk and his team.
Why It Matters: The potential appointment of Musk to the Department of Government Efficiency, also known as DOGE, has sparked controversy.&nbsp;Robert Reich, a former Clinton-era official, <a href="https://www.benzinga.com/politics/24/11/41962372/trumps-doge-with-musk-at-the-helm-riddled-with-conflicts-of-interest-says-clinton-era-official-robert-reich">criticized the move</a>, suggesting it could be riddled with conflicts of interest. Reich questioned the intentions behind forming this task force, implying it might not truly focus on efficiency.
Additionally, Musk&#8217;s views on drug use have drawn attention. In May, he humorously <a href="https://www.benzinga.com/news/24/05/38907748/days-after-facing-lawsuit-for-drug-use-musk-says-he-would-take-cocaine-if-it-boosted-long-term-produ">commented on&nbsp;X&nbsp;</a>about taking cocaine if it boosted productivity, following a lawsuit related to drug use. These factors contribute to the ongoing scrutiny surrounding Musk&#8217;s security clearance and potential government role.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/startups/24/12/42484881/musk-and-ramaswamy-may-target-this-surprising-government-role-that-pays-more-than-youd-think?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Musk and Ramaswamy May Target This Surprising Government Role That Pays More Than You&#8217;d Think</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Media

Elon Musk Doesn't Have Clearance For Certain SpaceX Programs Despite Being CEO: Report

BMO Capital analyst Bhavesh Lodaya maintains Element Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) with a Outperform and raises the price target from $32 to $34.

BMO Capital Maintains Outperform on Element Solutions, Raises Price Target to $34

Diana Shipping Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DSX#NYSE">DSX</a>), (the "Company"), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with China Resource Chartering Limited, for one of its Panamax dry bulk vessels, the m/v Maera. The gross charter rate is US$8,400 per day, minus a 5.00% commission paid to third parties, for a period until minimum September 20, 2025 up to maximum November 20, 2025. The charter commenced on December 15, 2024.
The "Maera" is a 75,403 dwt Kamsarmax dry bulk vessel built in 2013.
The employment of "Maera" is anticipated to generate approximately US$2.31 million of gross revenue for the minimum scheduled period of the time charter.

Diana Shipping Announces Time Charter Contract For m/v Maera; Gross Charter Rate Is $8,400 Per Day; Employment Of "Maera" Is Anticipated To Generate ~$2.31M Of Gross Revenue For The Minimum Scheduled Period Of The Time Charter

WIIM

AKTS

Akoustis Technologies shares are trading lower after the company announced it filed for Chapter 11 and is initiating the strategic sale of the business amid the Qorvo legal dispute.

JANA Partners ("JANA," "we" or "us") together with our strategic and operating partners beneficially own more than 5% of the outstanding shares of Lamb Weston Holdings, Inc. ("Lamb Weston" or the "Company"), making us one of the Company's largest shareholders. Having received no response from the Board to our months-long involvement and engagement, we are hopeful that the Company will use the upcoming fiscal second quarter earnings announcement to address our previously expressed view that significant Board and leadership change is needed at Lamb Weston, and that in its absence the Company should pursue a formal review of strategic alternatives, including a sale.
We believe Lamb Weston's Board and management have wasted the chance to sustain and grow shareholder value in a high-quality business. It is indisputable that Lamb Weston's track record for shareholders prior to the disclosure of our investment has been poor, not only in a disastrous 2024 (which includes an earnings report so ignominious that it prompted one long-tenured analyst to declare it "one of the worst days for a larger-cap food producer in modern history"),1 but also over the long-term with total returns in the last five years2 dramatically trailing the S&amp;P 500 and performing in the bottom quartile when compared to proxy peers.
Regrettably, we believe this dismal performance record significantly understates the magnitude of lost opportunity at the Company. Relative to its publicly traded packaged food peers, we believe Lamb Weston enjoys the benefits of an attractive end market, a strong industry position and key competitive advantages (including geographic ones). When coupled with Lamb Weston's long-time reputation as a premier foodservice supplier – which took prior management many years to build – we think these attributes should have positioned the Company as an attractive ‘compounder' stock and best-in-class performer for investors.
Instead, the current Board and management have overseen a multi-year period of uncorrelated failures across many major elements of operating the business, in the process damaging the Company's reputation and leading market position. This has impaired performance, dissolved confidence among customers, investors and other stakeholders and caused Lamb Weston to veer off its path as a world-class business.3
The disclosure of our involvement on October 18th led to an approximately $1 billion increase in Lamb Weston's market cap and an overwhelmingly positive reception from investors and Wall Street analysts,4 which we believe demonstrates the intense appetite from shareholders for a change in direction. The extensive investor feedback we have received since emerging publicly in the Company, including proprietary survey work that has included dozens of investors and other stakeholders, has further confirmed what was clear from our initial due diligence: that there is urgent need – and strong desire – for significant Board and leadership change at Lamb Weston.5
A failure of Board oversight has permitted chronic mis-execution, a bloated expense structure, poor capital allocation and questionable use and disclosure practices involving the Company's aviation assets. Making matters worse, the Board has supported management as Company leadership has attempted to place primary blame for the Company's challenges on end market softness – rather than offering a long overdue mea culpa and acknowledging the magnitude of damage inflicted on the business and investors from its litany of self-inflicted missteps.6 This contradicts what we believe to be an environment where the Company's primary competitors (all private companies) have enjoyed stronger performance at Lamb Weston's expense. This disconnect has not been lost on the investors and other stakeholders we have spoken with or who took part in a proprietary survey.7
Lamb Weston's failures include:
<ul>
<li>Significant Financial and Operating Deficiencies: These have cost the Company (at a minimum) nearly $400m8 in EBITDA over the past ~2.5 years and have eroded Lamb Weston's credibility with stakeholders across the value chain, from growers to customers.
<ul>
<li>A fumbled attempt to enhance its customer base by voluntarily ceasing business with some customers (i.e. ‘firing' them) before the Company had secured the superior replacement volume, resulting in lost market share and a volume shortfall that has weighed on revenue.</li>
<li>Mis-forecasting customer demand so dramatically that the Company has been forced to write off an inordinate amount of raw potatoes in both F2024 and F2025.9</li>
<li>Executing a multi-hundred million dollar ERP project riddled with delays (underway for almost a decade and now paused) where implementation failed so spectacularly that it left important Lamb Weston customers without products for a period in F3Q24, costing the Company both customers and reputational damage.</li>
<li>Failing to identify and address product quality problems for a key customer until so late in the process that the Company incurred ~$80m in losses from product withdrawal.</li>
<li>Generating little to no overhead cost leverage in the business despite doubling revenue over the last eight years,10 with the Company increasing its SG&amp;A targets from 8-8.5% sales to 10.5-11% in 2023.11</li>
</ul>
</li>
<li>Failed Oversight of Capital Allocation: The multi-year escalation of capital deployment – rubber-stamped by the Board and paired with misaligned incentives – led to elevated capex without acceptable returns, left the Company with no margin of safety when operational missteps surfaced, dramatically reduced free cash flow generation and eroded investor confidence in the Company. This includes:
<ul>
<li>An escalation in capital expenditures for new capacity so ill-conceived and poorly risk-managed that the new capacity subsequently necessitated the costly shuttering of existing capacity, including closing a manufacturing plant in Connell, WA and terminating nearly 400 employees.</li>
<li>Announcing a long-term capex target of 9%12 of revenue, substantially higher than stated maintenance capex levels of ~3% revenue, creating confusion around these elevated levels13 and with no clear roadmap for how the spend would generate sustainable and acceptable returns on capital.</li>
<li>Inexplicably permitting management to execute stock repurchases shortly before large earnings misses and dramatic declines in the Company's share price.14</li>
<li>Misaligned executive compensation targets that heavily incent growth, have no return on capital guardrails and have allowed management to earn the maximum amount (200%) of the target in FY24 on the operational performance component of the Long-Term Incentive Program's Performance Share Awards15 despite disastrous performance for investors.</li>
</ul>
</li>
<li>Questionable Use and Disclosure Practices around Aviation Assets:
<ul>
<li>Having a corporate plane to facilitate transport of employees between Boise, ID and key manufacturing locations is an understandable investment of corporate resources. However, our analysis of flight records shows that since 2019, Lamb Weston's plane has registered ~300 flights into or out of Omaha, NE – the former headquarters of Conagra and what appears to be the CEO's primary residence – and additional flights to numerous other destinations that raise questions regarding the legitimate business purpose of these flights. The Company's proxy disclosures – which show compensation of only $14,463, $13,737 and $21,349 of value for the CEO's personal use of Company aircraft in the years F2022, F2023 and F2024 and neither disclosure for any value received in earlier periods nor indication of plane usage for business purposes related to productivity and safety – seem to be at odds with our flight analysis, which raises serious questions about the use and disclosure around the Company's aviation assets.</li>
<li>In September 2023, shortly before the Company's 2023 Investor Day, when it created consternation and confusion among analysts and shareholders by announcing a new long-term capex target of 9% of revenue, Lamb Weston reserved two new tail numbers with the US Federal Aviation Administration. FAA Registry data shows these reservations were subsequently purged on October 18, 2024 – the day of JANA's 13D filing in Lamb Weston.</li>
</ul>
</li>
</ul>
This track record makes clear that the status quo is no longer tenable – and is completely unacceptable – for shareholders. JANA has a multi-decade reputation of working constructively with Boards to drive change and improve performance – in this spirit, our offer stands to work with Lamb Weston, as we and our team of highly regarded industry executives16 are prepared to join the Board immediately and help rehabilitate the Company and drive long-term value. However, if the Board is unwilling to make the significant changes needed to repair Lamb Weston, then the Company should work with its financial advisors to explore a sale and take advantage of strategic interest in the Company to achieve the highest possible risk-adjusted return for shareholders.
We look forward to the Board's prompt response.
Sincerely,
Scott Ostfeld Managing Partner &amp; Portfolio Manager

JANA Partners Sends Letter To Board Of Directors Of Lamb Weston Holdings; Believes Significant Board And Leadership Change Is Necessary To Improve Performance; Absent Meaningful Board And Leadership Change, Lamb Weston Should Launch A Formal Review Of Strategic Alternatives To Maximize Value For Shareholders

JP Morgan analyst Brian Cheng downgrades Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) from Neutral to Underweight.

Downgrades

JP Morgan Downgrades Editas Medicine to Underweight

Wedbush analyst Jay McCanless initiates coverage on Hovnanian Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOV#NYSE">HOV</a>) with a Neutral rating and announces Price Target of $155.

Comments

Defiance Quantum ETF

매도 수량

Defiance Quantum ETF (NASDAQ:QTUM), 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌